The following guidelines were approved at the Integrated Medicines Optimisation Committee (IMOC) meeting on 16 July 2025.
If you have any questions or require further clarification, please contact your ICB pharmacist.
|
Clinical Area |
Resource Location |
|
|
Continuous Glucose Monitoring (CGM) in people with Type 1 Diabetes Mellitus – Information for primary care |
||
|
Patient Information Leaflet: Prescribing and self-care information on vitamin D |
Prescribing/Medicines Guidance |
|
|
Interim position statement: Prescribing semaglutide (Wegovy®) and tirzepatide (Mounjaro®) for weight management on the NHS in North West London |
||
|
NHS North West London position statement on prescribing branded generic medicines |
||
|
Medicines Shortage Notification: Supply problems with quetiapine modified-release tablets updated June 2025 |
||
|
North West London guidance for optimisation of direct-acting oral anticoagulant prescribing in non-valvular atrial fibrillation |
Prescribing/Medicines Guidance |